Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/02/19 → 31/12/22 |
Clinical Trial Phase
- Phase III (a & b)
MIDAS 2. A Phase III, Multicentre, Prospective, Randomised, Placebo-controlled, Double-blind, Parallel group, with an adaptive sample size re-estimation study in Stroke Survivors.
- Cloud, Geoffrey (Primary Chief Investigator (PCI))
- Moore, Andrea (Project Manager)
Project: Research